Skip to main content
Jenscare Scientific Co., Ltd. logo

Jenscare Scientific Co., Ltd. — Investor Relations & Filings

Ticker · 9877 HKEX Manufacturing
Open in API
Filings indexed 198 across all filing types
Latest filing 2026-04-28 AGM Information
Country HK Hong Kong
Listing HKEX 9877

About Jenscare Scientific Co., Ltd.

http://www.jenscare.com

Jenscare Scientific Co., Ltd. is a medical device company dedicated to the research, development, and commercialization of innovative interventional products for the treatment of structural heart diseases. The company focuses on addressing unmet clinical needs by developing high-quality, safe, and effective therapeutic solutions. Jenscare has established a comprehensive product portfolio through independent innovation, offering a series of treatment solutions for various structural heart conditions. Core products include the LuX-Valve and Ken-Valve transcatheter valve systems. The company operates a full-cycle R&D function, spanning from the discovery of medical needs through product development to commercialization.

Recent filings

Filing Released Lang Actions
NOTICE OF 2025 ANNUAL GENERAL MEETING
AGM Information Classification · 1% confidence The document is a formal Notice of the 2025 Annual General Meeting (AGM) of Jenscare Scientific Co., Ltd., detailing the meeting date, venue, agenda items (ordinary and special resolutions), proxy arrangements, and procedural notes for shareholders. It is not the full annual report nor a results announcement, but rather the official notice for convening an AGM. This matches the definition of AGM Information (AGM-R).
2026-04-28 English
PROXY FORM FOR THE 2025 ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, 28 MAY 2026
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a proxy form (“Proxy Form for the 2025 Annual General Meeting”) used by shareholders to appoint proxies and vote at the AGM. This falls under proxy solicitation materials rather than the meeting’s results or the report itself. Therefore it should be classified as Proxy Solicitation & Information Statement (Code: PSI).
2026-04-28 English
2025 Annual Report
Annual Report Classification · 1% confidence The document is titled “2025 ANNUAL REPORT” for Jenscare Scientific Co., Ltd. and includes a full table of contents with sections such as Definitions, Corporate Information, Chief Executive Officer’s Statement, Management Discussion and Analysis, Directors’ Report, Independent Auditor’s Report, and complete consolidated financial statements and notes. It clearly constitutes a comprehensive yearly report covering full financial performance and corporate disclosures—not merely an announcement or summary—thus matching the Annual Report category. FY 2025
2026-04-28 English
(1) 2025 REPORT OF THE BOARD OF DIRECTORS (2) 2025 AUDITED FINANCIAL STATEMENTS (3) 2025 ANNUAL REPORT (4) 2025 PROFIT DISTRIBUTION PLAN (5) RE-APPOINTMENT OF AUDITOR (6) REMUNERATION OF DIRECTORS (7)
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a shareholder circular containing the Notice of the 2025 Annual General Meeting, agenda items, explanatory statements on resolutions, proxy form instructions, and information to solicit votes. This matches the definition of a Proxy Solicitation & Information Statement (materials sent to shareholders to provide meeting information and request votes).
2026-04-28 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
Regulatory Filings Classification · 1% confidence The document is a monthly return (Form FF301) submitted by Jenscare Scientific Co., Ltd. to the Hong Kong Exchange under Listing Rule Chapter 19B. It details movements in authorised and issued share capital, public float confirmations, and share‐related activities over the month. It is a routine regulatory compliance filing rather than an earnings release, report publication announcement, or specific transaction notice. It does not announce an actual new share issue, buyback, or board change but is a periodic disclosure required by the Exchange. This falls under the general “Regulatory Filings” (RNS) category as a miscellaneous listing rule compliance document.
2026-04-09 English
VOLUNTARY ANNOUNCEMENT iJensRobo ROBOT-ASSISTED TTVR SYSTEM COMPLETES FIRST CLINICAL STUDY
Regulatory Filings Classification · 1% confidence The document is a ‘VOLUNTARY ANNOUNCEMENT’ filed with the Hong Kong Stock Exchange to inform investors of a product development milestone (completion of the first clinical study of a robot-assisted TTVR system). It does not present financial results, changes in management or capital structure, dividends, or other specific categories. It is a general corporate announcement disclosing business progress, so it falls under the fallback category ‘Regulatory Filings’ (RNS).
2026-03-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.